The Healthcare Leadership Council (HLC) urges the U.S. Trade Representative to strengthen and restore intellectual property protections—especially for biopharmaceuticals—in the USMCA during its Joint Review, arguing this will boost innovation, investment, and North American competitiveness.
To The Administration
HLC comments support strengthening intellectual property provisions of USMACA
- Topics: Competition, Innovation
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To Congress
HLC response to Senate Finance Committee Democrats’ RFI on Health Coverage
HLC urged Congress to strengthen and modernize existing coverage pathways, strongly supporting restoring and building on the enhanced Affordable Care Act premium tax credits, simplifying enrollment and coverage renewal processes, promoting continuit…
To The Administration
Group letter to DOL on advancing the “Electronic Disclosure by Group Health Plans Under ERISA” proposed rule
Stakeholders representing employers, businesses, and environmental organizations urged the Department of Labor (DOL) to finalize its proposal to permit default electronic delivery (e-delivery) for group health plan communications under the Employee …
To Congress
Group letter urging House leadership to advance H.R. 2332/S.1101, the “SHARE Act”
HLC joined the Interstate Healthcare Collaborative and other healthcare organizations in urging House leadership to advance the bipartisan States Handling Access to Reciprocity for Employment (SHARE) Act (H.R. 2332/S. 1101). The legislation would ad…
